الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns | Novartis | Ongoing | N/A | 4 | VEG201319 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban | Thrombosis Research Institute | Ongoing | Rivaroxaban | 4 | TRI08890 | Armed Forces Hospital (Southern Region) |
| (FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients | Novartis | Ongoing | Ultibro breezhaler | 4 | A3405 V01 | King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah) |
| XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia | Bayer | Ongoing | Rivaroxaban | 4 | 17237 | King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah) |
| Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic | Astellas Pharma International | Ongoing | N/A | 4 | ONC-MA1002 | Aseer Central Hospital |
| Early Goal Directed Sedation vs. Standard Care Sedation | The Australian and New Zealand Intensive Care Research Centre, Monash University, Australia | Ongoing | Dexmedetomidine | 4 | YS/003 | King Saud Medical City (Riyadh) |
| Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial | King Abdulaziz City for Science and Technology (KACST) | Ongoing | Halita - AO ProRinse | 4 | PR oo39 | College of Dentistry King Saud University |
| easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment | Merck Serono | Ongoing | N/A | 4 | EMR200104-534 | King Fahad University Hospital (Al-Khobar), alhabib |
| Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE | Merck Serono | Ongoing | Erbitux (Cetuximab) | 4 | EMR062202-561 | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Postoperative Analgesic Effect ofDexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial | King Abdullah Medical City, Makkah | Ongoing | DEXMEDETOMIDINE | 2 | 14-119 | King Abdullah Medical City (Makkah) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.